Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07

Japanese classification of gastric carcinoma: 3rd English edition

Gastric Cancer · 2011 · 3.5K citations · Full text

Medicine, Oncology, Surgery +16

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

Salah‐Eddin Al‐Batran, Nils Homann, Claudia Pauligk et al. · The Lancet · 2019 · 2.6K citations · Full text

Medicine, Oncology, Perioperative Medicine +17

Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine

Shinichi Sakuramoto, Mitsuru Sasako, Toshiharu Yamaguchi et al. · New England Journal of Medicine · 2007 · 2.5K citations · Full text

Medicine, Oncology, Pharmacology +11

Japanese Classification of Gastric Carcinoma – 2nd English Edition –

Gastric Cancer · 1998 · 2.2K citations · Full text

Medicine, Oncology, Surgery +16

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

Yung‐Jue Bang, Young‐Woo Kim, Han‐Kwang Yang et al. · The Lancet · 2012 · 1.7K citations

Medicine, Oncology, Surgery +16